Mientras los funcionarios de salud corren para vacunar a la población contra COVID-19, los expertos han advertido que el virus podría volverse endémico, lo que significa que los canadienses podrían necesitar inyecciones de refuerzo para asegurarse de estar protegidos en los próximos años.

¿Cómo planea el gobierno asegurar y proporcionar vacunas de refuerzo a los canadienses?

He aquí un vistazo más de cerca.

Leer más:

Rastreador de vacunas COVID-19: ¿Cuántos canadienses están vacunados?

En una declaración enviada por correo electrónico a Global News, Salud Canadá dijo que la trayectoria futura esperada del nuevo coronavirus y la pandemia “aún no está clara, ni tampoco la evolución futura de las variantes del virus y su gravedad”.

La agencia dice que actualmente no hay vacunas en el mercado que se hayan desarrollado específicamente como inyecciones de refuerzo o que se dirijan específicamente a las nuevas variantes más transmisibles.

Sin embargo, Health Canada dice que hay algunas vacunas que están “en desarrollo temprano”.

La historia continúa debajo del anuncio.

“Se está trabajando para definir nuestras futuras necesidades de refuerzo, tanto en términos de cantidades como de tecnologías de vacunas en las que centrarnos”, se lee en el comunicado. “Canadá está en conversaciones con los desarrolladores de vacunas sobre los planes para el acceso temprano y seguro a las vacunas de refuerzo y variantes cuando estén disponibles”.

La agencia dijo que el gobierno federal “continuará adoptando un enfoque basado en la evidencia para sus decisiones de adquisición de vacunas” y está “siguiendo el consejo de los expertos en términos de planificación de cuáles serán las posibles necesidades futuras de vacunas de Canadá y cómo esas necesidades pueden ser”. mejor dirigido “.


Haga clic para reproducir el video: 'Fauci analiza la posible trayectoria de la pandemia de COVID-19 en EE. UU.'



Fauci analiza la posible trayectoria de la pandemia de COVID-19 en EE. UU.


Fauci analiza la posible trayectoria de la pandemia de COVID-19 en EE. UU.

Actualmente, Canadá está recibiendo todas sus vacunas COVID-19 del extranjero.

Esto ha resultado difícil para el plan de vacunación masiva del país, ya que varios retrasos de los fabricantes han estancado la implementación.

Canadá se ha quedado muy por detrás de sus aliados más cercanos en lo que respecta a la vacunación.

La historia continúa debajo del anuncio.

As of Sunday afternoon, just over five million COVID-19 vaccine doses had been administered across the country, meaning approximately 6.47 per cent of the Canadian population has been vaccinated.

In comparison, 140 million doses have been given in the United States. That means 14.42 per cent of the American population has been inoculated against the virus so far.

Read more:
Where is Canada now in its rollout of the COVID-19 vaccine?

Canada’s lack of domestic vaccine manufacturing capability has been “highlighted as a health security threat,” Dr. Isaac Bogoch, an infectious diseases faculty member at the University of Toronto said.

“And it is,” he continued. “But I don’t think that’s lost on the Canadian government and the local governments.”

In a statement emailed to Global News, Innovation, Science and Economic Development Canada (ISED) said the federal government is “investing in made-in-Canada projects to protect Canadians from COVID-19” and “ensure our country is well-positioned to fight future pandemics here at home.”

Story continues below advertisement

The agency said Canada is “developing domestic biomanufacturing capacity,” and by doing so, the government will “be able to ensure that both the quality and the availability of vaccines and therapeutic drugs is secure going forward.”

Read more:
30 travellers entering Canada caught with suspected fake COVID-19 test results: CBSA

According to ISED, since the beginning of the pandemic, the government has allocated $792 million under the new Strategic Innovation Fund COVID-19 stream in order to deliver “direct support to Canadian companies; in particular, helping develop domestic COVID-19 vaccines, therapies and bio-manufacturing opportunities, while also building future capability.”

The agency said this is in addition to supports provided to the National Research Council, for the facilities at Royalmount, and VIDO-Intervac, and through other government funding programs.

Bogoch said there has been a “tremendous investment” to produce vaccines at home, pointing to the government’s deal to manufacture shots at a facility in Montreal.

The federal government announced last month it had struck a deal with Novavax to produce its COVID-19 vaccine candidate in Canada at a new Montreal facility that is under construction.

However, doses are not expected to be manufactured in the country until at least the fall.

Story continues below advertisement


Click to play video: 'Americans race to get vaccinated as COVID-19 surges'



Americans race to get vaccinated as COVID-19 surges


Americans race to get vaccinated as COVID-19 surges

“Is that enough? No, but it’s a really good start in the local production of vaccine,” Bogoch said.

He also said there are a number of companies within Canada that are “innovating and creating homegrown COVID-19 vaccines as well.”

“I don’t think you’re going to flip a switch overnight and all of a sudden re-create your vaccine creation and manufacturing capability,” he said. “It’s obvious you need to require a sustained investment over time, not just at the manufacturing level, but also at the innovation level and the basic science level.”

Read more:
Path out of COVID-19 pandemic isn’t easy, but there’s hope: experts

ISED said the federal government has “worked with Canadian and international companies to explore opportunities to bring elements of the COVID-19 vaccine manufacturing supply chain to Canada, and will continue to do whatever it can to assist interested firms in finding partners to that end.”

Story continues below advertisement

According to the agency, consultations have also been launched to ensure Canada is “prepared and ready for future pandemics, including through vaccine and therapeutics manufacturing.”



© 2021 Global News, a division of Corus Entertainment Inc.

.



Source link